SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss
SheMed built a $1 billion business on GLP-1s. Its next venture focuses on going beyond weight loss. Inc.com reports on this promising new direction.
SheMed built a $1 billion business on GLP-1s. Its next venture focuses on going beyond weight loss. Inc.com reports on this promising new direction.